DK0513316T3 - Analytiske markører for cancer, især malign brystcancer - Google Patents

Analytiske markører for cancer, især malign brystcancer

Info

Publication number
DK0513316T3
DK0513316T3 DK92901155.9T DK92901155T DK0513316T3 DK 0513316 T3 DK0513316 T3 DK 0513316T3 DK 92901155 T DK92901155 T DK 92901155T DK 0513316 T3 DK0513316 T3 DK 0513316T3
Authority
DK
Denmark
Prior art keywords
cancer
breast cancer
malignant breast
especially malignant
analytical markers
Prior art date
Application number
DK92901155.9T
Other languages
Danish (da)
English (en)
Inventor
Paul Basset
Jean-Pierre Bellocq
Pierre Chambon
Original Assignee
Inst Nat Sant Et De La Rech M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sant Et De La Rech M filed Critical Inst Nat Sant Et De La Rech M
Application granted granted Critical
Publication of DK0513316T3 publication Critical patent/DK0513316T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK92901155.9T 1990-11-21 1991-11-21 Analytiske markører for cancer, især malign brystcancer DK0513316T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9025326A GB2250993B (en) 1990-11-21 1990-11-21 Stromelysin-3 and its application in the diagnosis and treatment of malignant breast cancer

Publications (1)

Publication Number Publication Date
DK0513316T3 true DK0513316T3 (da) 1997-05-20

Family

ID=10685753

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92901155.9T DK0513316T3 (da) 1990-11-21 1991-11-21 Analytiske markører for cancer, især malign brystcancer

Country Status (16)

Country Link
US (1) US5236844A (es)
EP (1) EP0513316B1 (es)
JP (1) JP3516448B2 (es)
AT (1) ATE152179T1 (es)
CA (1) CA2073860A1 (es)
DE (1) DE69125824T2 (es)
DK (1) DK0513316T3 (es)
ES (1) ES2101079T3 (es)
GB (1) GB2250993B (es)
GR (1) GR3023560T3 (es)
HU (1) HU215165B (es)
IE (1) IE914056A1 (es)
NZ (2) NZ260705A (es)
PT (1) PT99562B (es)
WO (1) WO1992009701A1 (es)
ZA (1) ZA919219B (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2150125A1 (en) * 1992-11-25 1994-06-09 Timothy R. Billiar Cdna clone for human inducible nitric oxide synthase and process for preparing same
AU7401394A (en) * 1993-07-20 1995-02-20 University Of Massachusetts Medical Center In vivo nucleic acid hybridization method
DE69412466T2 (de) * 1993-11-30 1999-04-29 Fuji Yakuhin Kogyo Kk Neue metalloprotease und kodierende dna dafür
US6825024B1 (en) 1993-11-30 2004-11-30 Fuji Yakuhin Kogyo Kabushiki Kaisha Metalloproteinase and encoding DNA therefor
JPH07303482A (ja) 1993-11-30 1995-11-21 Fuji Yakuhin Kogyo Kk 新規なメタロプロテアーゼおよびそれをコードするｄｎａ
US5710001A (en) * 1994-08-12 1998-01-20 Myriad Genetics, Inc. 17q-linked breast and ovarian cancer susceptibility gene
US5753441A (en) * 1994-08-12 1998-05-19 Myriad Genetics, Inc. 170-linked breast and ovarian cancer susceptibility gene
US5747282A (en) * 1994-08-12 1998-05-05 Myraid Genetics, Inc. 17Q-linked breast and ovarian cancer susceptibility gene
US5709999A (en) * 1994-08-12 1998-01-20 Myriad Genetics Inc. Linked breast and ovarian cancer susceptibility gene
US5763415A (en) * 1995-08-03 1998-06-09 John Hopkins University School Of Medicine Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer
US5883241A (en) * 1995-09-05 1999-03-16 Celltech Therapeutics Limited DNA sequences coding for a human metalloproteinase and variants thereof
US5905027A (en) * 1995-12-27 1999-05-18 Uab Research Foundation Method of diagnosing and treating gliomas
WO1997040157A1 (en) * 1996-04-25 1997-10-30 Takeda Chemical Industries, Ltd. Matrix metalloprotease
WO1998018945A1 (en) * 1996-10-31 1998-05-07 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
US20030165971A1 (en) * 1996-10-31 2003-09-04 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
US20050153373A1 (en) * 1996-10-31 2005-07-14 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
US20050202499A1 (en) 1996-10-31 2005-09-15 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
CA2273847C (en) * 1996-12-06 2013-08-13 Urocor, Inc. Diagnosis of disease state using mrna profiles
WO1998040475A1 (en) * 1997-03-11 1998-09-17 Abbott Laboratories Human matrix metalloprotease gene, proteins encoded therefrom and methods of using same
CA2284039A1 (en) 1997-03-18 1998-09-24 Ortho-Mcneil Pharmaceutical, Inc. Methods and kits for treating and diagnosing leiomyomas
US6190857B1 (en) 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
US7332270B1 (en) 1997-03-24 2008-02-19 Urocor, Inc. Diagnosis of disease state using mRNA profiles in peripheral leukocytes
US20040072210A1 (en) * 1997-07-07 2004-04-15 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
WO1999002714A1 (en) * 1997-07-07 1999-01-21 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
US20020037503A1 (en) * 1997-11-17 2002-03-28 Patricia A. Billing-Medel Reagents and methods useful for detecting diseases of the breast
US5972615A (en) 1998-01-21 1999-10-26 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
US6600057B2 (en) 2000-12-29 2003-07-29 Kimberly-Clark Worldwide, Inc. Matrix metalloproteinase inhibitors
US7041787B2 (en) * 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases
WO2003006641A2 (en) * 2001-07-09 2003-01-23 Københavns Universitet Epsti1, a gene induced by epithelial-stromal interaction in human breast cancer
US20030119073A1 (en) * 2001-12-21 2003-06-26 Stephen Quirk Sensors and methods of detection for proteinase enzymes
DE10217254A1 (de) 2002-04-15 2003-10-23 Proteosys Ag Verwendung von Substanzen zur Behandlung von Tumoren
US20060088899A1 (en) * 2002-05-31 2006-04-27 Alvarez Vernon L Combination chemotherapy with chlorotoxin
US20050193432A1 (en) * 2003-11-18 2005-09-01 Whitehead Institute For Biomedical Research Xenograft model of functional normal and malignant human breast tissues in rodents and methods thereof
US7667001B1 (en) * 2004-01-27 2010-02-23 Compugen Ltd. Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
US7569662B2 (en) * 2004-01-27 2009-08-04 Compugen Ltd Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
US20090191543A1 (en) * 2005-05-27 2009-07-30 Theregents Of The University Of California Identification of rac1b as a marker and mediator of metalloproteinase-induced malignancy
AU2009246142A1 (en) 2008-05-15 2009-11-19 Transmolecular, Inc. Treatment of metastatic tumors
LT2531206T (lt) 2010-02-04 2017-09-25 Morphotek, Inc. Chlorotoksino polipeptidai ir konjugatai ir jų naudojimas
EP2569330B1 (en) 2010-05-11 2016-09-28 Fred Hutchinson Cancer Research Center Chlorotoxin variants, conjugates, and methods for their use
KR101313184B1 (ko) * 2010-06-24 2013-09-30 한국표준과학연구원 질병 지표 검출 키트 및 질병 지표 검출 방법
AU2013359429A1 (en) 2012-12-10 2015-07-09 Fred Hutchinson Cancer Research Center Methods for screening
US11559580B1 (en) 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0269724A1 (en) * 1986-06-17 1988-06-08 Celltech Limited Process for the production of a protein

Also Published As

Publication number Publication date
WO1992009701A1 (fr) 1992-06-11
GR3023560T3 (en) 1997-08-29
GB2250993A (en) 1992-06-24
HUT65373A (en) 1994-05-02
EP0513316B1 (fr) 1997-04-23
JPH05505530A (ja) 1993-08-19
IE914056A1 (en) 1992-06-03
JP3516448B2 (ja) 2004-04-05
GB9025326D0 (en) 1991-01-02
ZA919219B (en) 1992-10-28
AU9089691A (en) 1992-06-25
NZ260705A (en) 1997-05-26
HU215165B (hu) 1998-10-28
US5236844A (en) 1993-08-17
DE69125824D1 (de) 1997-05-28
ES2101079T3 (es) 1997-07-01
CA2073860A1 (en) 1992-05-22
HU9202368D0 (en) 1992-10-28
PT99562B (pt) 1999-04-30
EP0513316A1 (fr) 1992-11-19
GB2250993B (en) 1995-02-15
NZ240688A (en) 1994-09-27
PT99562A (pt) 1992-10-30
ATE152179T1 (de) 1997-05-15
DE69125824T2 (de) 1997-08-07
AU646914B2 (en) 1994-03-10

Similar Documents

Publication Publication Date Title
DK0513316T3 (da) Analytiske markører for cancer, især malign brystcancer
DE69940264D1 (de) Krebsantigene, basierend auf dem tumorunterdrückenden genprodukt wt1
NZ593289A (en) Anti-neuropilin-1 antibodies for treating angiogenesis
DE69942827D1 (de) Verwendung der epothilons zur behandlung der krebs
DE602004015811D1 (de) Verfahren zur inhibierung der proliferation von tumorzellen, bei dem platinkomplexe eingesetzt werden
MX9804009A (es) Inhibicion de crecimiento tumoral por oligonucleotidos de antisentido para il-8 y receptor de il-8.
BR0209646A (pt) genes expressos em cáncer de mama como alvos de prognósticos e terapêuticos
DK1210115T3 (da) Doseringer til behandling med anti-ErB2-antistoffer
PT1255537E (pt) Inibidores da proteina farnesil transferase para tratar cancro da mama
EP0552296A4 (en) Mouse monoclonal antibodies
BR0306715A (pt) Métodos para diagnóstico e tratamento de tumores
EA200001133A1 (ru) Антипикорнавирусные композиции, их получение и применение
ATE332979T1 (de) Detektion von änderungen von tumor-suppressor genen zur diagnose von krebs
DE59008813D1 (de) Mittel zur neutralisierung der tumorzellen-assoziierten prokoagulant-aktivität.
GB9924957D0 (en) Novel treatment
WO2009075803A3 (en) Alternative splice variant patterns of human telomerase reverse transcriptase (htert) in thyroid tumors to distinguish benign from malignant
BR0215689A (pt) Composição farmacêutica compreendendo arsênico para o tratamento de malignidade
ATE298003T1 (de) Ein tumorsuppressor namens ts10q23.3
ATE397673T1 (de) Verstärktes krebs-gen wip1
ATE329597T1 (de) Die verwendung von einer 4- pyridylmethylphtalazine enthaltenden kombination zur behandlung von tumoren
DE10307103A8 (de) Antitumor wirksame 2-substituierte D-Homoestra-1,3,5(10)-trien-3-yl sulfamate
DK1261325T3 (da) Tumorinhiberende sammensætninger, der indeholder nitroacridiner
HUP0402639A2 (hu) Szubsztituált akriloil-disztamicin-származékokat és protein kináz (szerin/treonin kináz) inhibitorokat tartalmazó tumorellenes kombinációs készítmény és alkalmazása
ATE202284T1 (de) Ein extrakt aus muscheln, extraktionsmethoden und verwendungen davon
EP1438388A4 (en) IBC-1 (INVASIVE-1 BREAST CANCER), ONCOGEN PRESUME AMPLIFIED IN BREAST CANCER